1. Home
  2. NBTX vs EAF Comparison

NBTX vs EAF Comparison

Compare NBTX & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • EAF
  • Stock Information
  • Founded
  • NBTX 2003
  • EAF 1886
  • Country
  • NBTX France
  • EAF United States
  • Employees
  • NBTX N/A
  • EAF N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • EAF Industrial Machinery/Components
  • Sector
  • NBTX Health Care
  • EAF Energy
  • Exchange
  • NBTX Nasdaq
  • EAF Nasdaq
  • Market Cap
  • NBTX 178.7M
  • EAF 169.7M
  • IPO Year
  • NBTX 2020
  • EAF 1995
  • Fundamental
  • Price
  • NBTX $3.29
  • EAF $0.64
  • Analyst Decision
  • NBTX Strong Buy
  • EAF Hold
  • Analyst Count
  • NBTX 1
  • EAF 6
  • Target Price
  • NBTX $8.00
  • EAF $1.68
  • AVG Volume (30 Days)
  • NBTX 11.4K
  • EAF 3.1M
  • Earning Date
  • NBTX 04-02-2025
  • EAF 04-25-2025
  • Dividend Yield
  • NBTX N/A
  • EAF N/A
  • EPS Growth
  • NBTX N/A
  • EAF N/A
  • EPS
  • NBTX N/A
  • EAF N/A
  • Revenue
  • NBTX N/A
  • EAF $538,782,000.00
  • Revenue This Year
  • NBTX N/A
  • EAF $0.09
  • Revenue Next Year
  • NBTX $277.81
  • EAF $23.33
  • P/E Ratio
  • NBTX N/A
  • EAF N/A
  • Revenue Growth
  • NBTX N/A
  • EAF N/A
  • 52 Week Low
  • NBTX $2.76
  • EAF $0.52
  • 52 Week High
  • NBTX $7.51
  • EAF $2.53
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 46.34
  • EAF 35.82
  • Support Level
  • NBTX $3.28
  • EAF $0.59
  • Resistance Level
  • NBTX $3.53
  • EAF $0.76
  • Average True Range (ATR)
  • NBTX 0.18
  • EAF 0.10
  • MACD
  • NBTX 0.00
  • EAF -0.00
  • Stochastic Oscillator
  • NBTX 46.48
  • EAF 16.44

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About EAF GrafTech International Ltd.

GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.

Share on Social Networks: